Cytokinetics Inc vs OneSpan Inc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while OneSpan Inc trades at $16.25 (market cap $600.69M). The key difference: Cytokinetics Inc is far larger — about 17.7× OneSpan Inc's market cap, and OneSpan Inc pays a 3.19% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | OSPN | |
|---|---|---|
Market Cap | $10.63B | $600.69M |
Sector | Technology | Technology |
52-Week High | $87.26 | $16.78 |
52-Week Low | $34.31 | $10.15 |
Enterprise Value | $10.74B | $569.77M |
Dividend Yield | — | 3.19% |
Trailing returns across standard periods
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →